Data / Drug companies / Suspension
Companies that list suspension products: 281 companies and 1,156 products in the FDA NDC directory
The FDA National Drug Code Directory lists 1,156 products that are suspension products from 281 companies. The ten largest listers hold 19.6% of them, and the newest started marketing on October 22, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies
- 281
- Products
- 1,156
- Drugs by generic name
- 155
- Main marketing category
- Generic drugs (ANDA)
Companies that list suspension products
Ranked by number of products in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Walgreen Company | 38 | suspension | Over the counter monograph drugs | March 6, 2026 |
| Pai Holdings, LLC DBA Pai Pharma | 24 | suspension | Over the counter monograph drugs | October 17, 2025 |
| Amazon.com Services LLC | 23 | suspension | Generic drugs (ANDA) | October 22, 2026 |
| Atlantic Biologicals Corp. | 23 | suspension | Generic drugs (ANDA) | February 20, 2025 |
| Preferred Pharmaceuticals Inc. | 22 | suspension | Generic drugs (ANDA) | September 24, 2026 |
| Strategic Sourcing Services LLC | 22 | suspension | Over the counter monograph drugs | December 5, 2025 |
| Kenvue Brands LLC | 21 | suspension | Over the counter monograph drugs | April 13, 2026 |
| A-S Medication Solutions | 18 | suspension | Generic drugs (ANDA) | August 15, 2024 |
| Cardinal Health 110, LLC. DBA Leader | 18 | suspension | Over the counter monograph drugs | October 21, 2024 |
| L. Perrigo Company | 18 | suspension | Generic drugs (ANDA) | May 7, 2026 |
| Precision Dose, Inc. | 18 | suspension | Generic drugs (ANDA) | October 9, 2026 |
| Wal-Mart Stores Inc | 18 | suspension | Over the counter monograph drugs | September 3, 2020 |
| Bryant Ranch Prepack | 17 | suspension | Generic drugs (ANDA) | May 12, 2025 |
| CVS Woonsocket Prescription Center, Incorporated | 16 | suspension | Over the counter monograph drugs | April 16, 2026 |
| Chartwell RX, LLC | 16 | suspension | Generic drugs (ANDA) | April 14, 2025 |
| H E B | 16 | suspension | Over the counter monograph drugs | October 31, 2023 |
| Aurohealth LLC | 15 | suspension | Over the counter monograph drugs | August 31, 2026 |
| Meijer Distribution Inc | 15 | suspension | Over the counter monograph drugs | March 15, 2017 |
| Dolgencorp, Inc. (dollar General & Rexall) | 14 | suspension | Over the counter monograph drugs | March 17, 2025 |
| Kesin Pharma Corporation | 14 | suspension | Generic drugs (ANDA) | February 27, 2026 |
| Topco Associates LLC | 14 | suspension | Over the counter monograph drugs | December 1, 2020 |
| American Health Packaging | 13 | suspension | Generic drugs (ANDA) | May 15, 2026 |
| CVS Pharmacy | 13 | suspension | Generic drugs (ANDA) | August 31, 2015 |
| Kroger Company | 13 | suspension | Over the counter monograph drugs | June 15, 2024 |
| Major Pharmaceuticals | 13 | suspension | Generic drugs (ANDA) | January 8, 2026 |
| Rite Aid Corporation | 13 | suspension | Over the counter monograph drugs | April 7, 2023 |
| Safeway | 13 | suspension | Over the counter monograph drugs | May 4, 2026 |
| American Sales Company | 12 | suspension | Over the counter monograph drugs | February 18, 2018 |
| Genexa Inc. | 12 | suspension | Over the counter monograph drugs | September 8, 2026 |
| NuCare Pharmaceuticals,Inc. | 12 | suspension | Generic drugs (ANDA) | December 5, 2022 |
| Sun Pharmaceutical Industries, Inc. | 12 | suspension | Generic drugs (ANDA) | June 16, 2026 |
| Target Corporation | 12 | suspension | Over the counter monograph drugs | June 16, 2025 |
| Cardinal Health 107, LLC | 11 | suspension | Generic drugs (ANDA) | October 31, 2024 |
| E-Z-Em Canada Inc | 11 | suspension | New drug applications (NDA) | November 1, 2020 |
| Ani Pharmaceuticals, Inc. | 10 | suspension | Generic drugs (ANDA) | May 14, 2026 |
| Chain Drug Marketing Association | 10 | suspension | Over the counter monograph drugs | February 1, 2021 |
| Geri-Care Pharmaceuticals, Corp | 10 | suspension | Over the counter monograph drugs | July 1, 2024 |
| Opmx LLC | 10 | suspension | Over the counter monograph drugs | September 5, 2026 |
| Valu Merchandisers Company | 10 | suspension | Over the counter monograph drugs | January 1, 2025 |
| Amerisource Bergen | 9 | suspension | Over the counter monograph drugs | January 21, 2026 |
| Camber Pharmaceuticals, Inc. | 9 | suspension | Generic drugs (ANDA) | March 5, 2026 |
| Family Dollar (family Wellness) | 9 | suspension | Over the counter monograph drugs | November 26, 2024 |
| Proficient Rx LP | 9 | suspension | Generic drugs (ANDA) | July 16, 2018 |
| Publix Super Markets Inc | 9 | suspension | Over the counter monograph drugs | August 1, 2021 |
| Bryant Ranch Prepack | 8 | suspension | Generic drugs (ANDA) | August 14, 2020 |
| CVS Pharmacy | 8 | suspension | Over the counter monograph drugs | September 1, 2020 |
| Chartwell Governmental & Specialty RX, LLC. | 8 | suspension | Generic drugs (ANDA) | April 14, 2025 |
| HyVee Inc | 8 | suspension | Generic drugs (ANDA) | March 18, 2026 |
| Amneal Pharmaceuticals LLC | 7 | suspension | Generic drugs (ANDA) | December 2, 2019 |
| AptaPharma Inc. | 7 | suspension | Over the counter monograph drugs | March 1, 2026 |
| Aurobindo Pharma Limited | 7 | suspension | Generic drugs (ANDA) | October 3, 2025 |
| Haleon US Holdings LLC | 7 | suspension | New drug applications (NDA) | December 20, 2013 |
| Padagis Israel Pharmaceuticals Ltd | 7 | suspension | Generic drugs (ANDA) | April 9, 2014 |
| Amneal Pharmaceuticals NY LLC | 6 | suspension | Generic drugs (ANDA) | September 8, 2023 |
| Perrigo Direct, Inc | 6 | suspension | Over the counter monograph drugs | July 1, 2020 |
| United Natural Foods, Inc. DBA Unfi | 6 | suspension | Generic drugs (ANDA) | October 15, 2014 |
| Walmart Inc. | 6 | suspension | Over the counter monograph drugs | August 20, 2026 |
| Akron Pharma Inc. | 5 | suspension | Over the counter monograph drugs | September 13, 2024 |
| Bionpharma Inc. | 5 | suspension | Generic drugs (ANDA) | September 8, 2025 |
| Demoulas Super Markets, Inc | 5 | suspension | Over the counter monograph drugs | January 1, 2026 |
| Hikma Pharmaceuticals USA Inc. | 5 | suspension | Generic drugs (ANDA) | June 16, 2025 |
| Infirst Healthcare Inc. | 5 | suspension | Over the counter monograph drugs | August 15, 2026 |
| Randob Labs,ltd. DBA Crossingwell Consumer Health | 5 | suspension | Over the counter monograph drugs | July 15, 2023 |
| Teva Pharmaceuticals USA, Inc. | 5 | suspension | Generic drugs (ANDA) | January 11, 2019 |
| WinCo Foods, LLC | 5 | suspension | Over the counter monograph drugs | August 15, 2026 |
| Advagen Pharma Ltd | 4 | suspension | Generic drugs (ANDA) | March 5, 2026 |
| Amerisource Bergen | 4 | suspension | Generic drugs (ANDA) | May 13, 2002 |
| Amneal Pharmaceuticals of New York LLC | 4 | suspension | Generic drugs (ANDA) | August 4, 2016 |
| Belleview Bioscience LLC | 4 | suspension | Drugs for further processing | November 1, 2025 |
| CMP Pharma, Inc. | 4 | suspension | New drug applications (NDA) | March 1, 2023 |
| Camber Consumer Care Inc | 4 | suspension | Generic drugs (ANDA) | September 18, 2019 |
| KinderFarms, LLC | 4 | suspension | Over the counter monograph drugs | July 1, 2026 |
| Mollec Inc | 4 | suspension | Generic drugs (ANDA) | June 1, 2026 |
| NorthStar RxLLC | 4 | suspension | Generic drugs (ANDA) | August 1, 2024 |
| Novadoz Pharmaceuticals LLC | 4 | suspension | Generic drugs (ANDA) | May 29, 2026 |
| P & L Development, LLC | 4 | suspension | Over the counter monograph drugs | July 31, 2024 |
| Rugby Laboratories | 4 | suspension | Over the counter monograph drugs | March 25, 2024 |
| Spi Pharma, Inc. | 4 | suspension | Drugs for further processing | January 17, 2023 |
| The Procter & Gamble Manufacturing Company | 4 | suspension | Over the counter monograph drugs | March 1, 2018 |
| VistaPharm, LLC | 4 | suspension | Over the counter monograph drugs | December 13, 2024 |
| Aarna USA Inc. | 3 | suspension | Over the counter monograph drugs | July 22, 2025 |
| Actavis Pharma, Inc. | 3 | suspension | Generic drugs (ANDA) | July 16, 2018 |
| Ascend Laboratories, LLC | 3 | suspension | Generic drugs (ANDA) | May 7, 2021 |
| AstraZeneca Pharmaceuticals LP | 3 | suspension | New drug applications (NDA) | September 17, 2007 |
| Azurity Pharmaceuticals, Inc. | 3 | suspension | New drug applications (NDA) | June 10, 2024 |
| Azurity Pharmaceuticals, Inc. | 3 | suspension | New drug applications (NDA) | July 15, 2022 |
| Biocon Pharma Inc. | 3 | suspension | Generic drugs (ANDA) | September 25, 2026 |
| Bryant Ranch Prepack | 3 | suspension | Generic drugs (ANDA) | April 9, 2014 |
| Chain Drug Marketing Association, Inc. | 3 | suspension | Over the counter monograph drugs | September 1, 2026 |
| Chattem, Inc. | 3 | suspension | New drug applications (NDA) | May 1, 2026 |
| Cipla USA Inc. | 3 | suspension | Generic drugs (ANDA) | April 3, 2025 |
| Cosette Pharmaceuticals, Inc. | 3 | suspension | Generic drugs (ANDA) | December 19, 2024 |
| Fagron Inc | 3 | suspension | Bulk ingredients for compounding | January 2, 2012 |
| Genetix Biotherapeutics Inc. | 3 | suspension | Biologics (BLA) | December 8, 2023 |
| GlaxoSmithKline Biologicals SA | 3 | suspension | Biologics (BLA) | July 1, 2026 |
| J. Strickland & Co. | 3 | suspension | Over the counter monograph drugs | January 1, 2020 |
| Kite Pharma, Inc. | 3 | suspension | Biologics (BLA) | October 1, 2021 |
| Kroger Company | 3 | suspension | Over the counter monograph drugs | September 21, 2026 |
| Long Grove Pharmaceuticals, LLC | 3 | suspension | Generic drugs (ANDA) | May 2, 2022 |
| Meijer, Inc. | 3 | suspension | Over the counter monograph drugs | August 1, 2025 |
Drugs most often listed
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.